Kenneth Janzon
Hoofd Techniek/Wetenschap/O&O bij Nordvacc Läkemedel AB
Vermogen: 439 236 $ op 30-04-2024
Actieve functies van Kenneth Janzon
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Nordvacc Läkemedel AB
Nordvacc Läkemedel AB Medical DistributorsDistribution Services Part of Intervacc AB, Nordvacc Läkemedel AB is a veterinary pharmaceutical company based in Hägersten, SE. Nordvacc Läkemedel AB was acquired by Sorkaruga AB on March 25, 2014. The Swedish company specializes in the distribution and marketing of veterinary vaccines and medicines for the care and treatment of both companion and farm animals. The company's flagship product, infucal® vet, is a solution for calving paralysis and is vital for the survival of cattle. The product contains calcium, magnesium, a source of phosphorus in the form of sodium hypophosphite, and glucose, which counteracts hypomagnesemia and is used to treat other conditions with hypocalcemia in animals. The CEO of the company is Rune Bergman. | Hoofd Techniek/Wetenschap/O&O | - | - |
Loopbaan van Kenneth Janzon
Eerdere bekende functies van Kenneth Janzon
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
INTERVACC AB | Directeur/Bestuurslid | 01-01-2001 | 14-06-2018 |
Oprichter | 01-01-2001 | 14-06-2018 | |
Independent Dir/Board Member | 01-01-2001 | - |
Statistieken
Internationaal
Zweden | 3 |
Operationeel
Director/Board Member | 1 |
Founder | 1 |
Independent Dir/Board Member | 1 |
Sectoraal
Health Technology | 2 |
Distribution Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
INTERVACC AB | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Nordvacc Läkemedel AB
Nordvacc Läkemedel AB Medical DistributorsDistribution Services Part of Intervacc AB, Nordvacc Läkemedel AB is a veterinary pharmaceutical company based in Hägersten, SE. Nordvacc Läkemedel AB was acquired by Sorkaruga AB on March 25, 2014. The Swedish company specializes in the distribution and marketing of veterinary vaccines and medicines for the care and treatment of both companion and farm animals. The company's flagship product, infucal® vet, is a solution for calving paralysis and is vital for the survival of cattle. The product contains calcium, magnesium, a source of phosphorus in the form of sodium hypophosphite, and glucose, which counteracts hypomagnesemia and is used to treat other conditions with hypocalcemia in animals. The CEO of the company is Rune Bergman. | Distribution Services |
- Beurs
- Insiders
- Kenneth Janzon
- Ervaring